You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《盈警響號》常茂生物(00954.HK)料上半年綜合淨利潤跌至少於100萬人幣
阿思達克 08-03 17:04
常茂生物(00954.HK)發盈警,料今年上半年歸屬於公司權益持有人的綜合淨利潤將少於100萬元人民幣(下同),較去年同期的1,517.8萬元純利大幅下降。 公告指期內財務表現受影響主要因為為配合政府政策變更,公司必須關閉及搬遷位於常州市受影響工廠區的某些生產線,集團對外採購順酐金額較去年同期增加了超過一倍;集團順酐每噸平均成本價較去年同期上升超過45%,導致毛利率大幅下降等。 常茂生物指目前正在遼寧省大連市長興島興建新工廠,並把常州工廠和連雲港工廠的順酐生產線搬遷到大連新工廠。董事會預期大連新工廠投產後,集團順酐生產將回復正常。(el/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account